Equities Research Analysts’ Updated EPS Estimates for April 1st (APLS, BAB, BKG, BTRW, FCNCA, HOPE, IVN, JPM, NKE, NOW)

Equities Research Analysts’ updated eps estimates for Wednesday, April 1st:

Apellis Pharmaceuticals (NASDAQ:APLS) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $41.00 price target on the stock, up from their previous price target of $37.00.

Babcock International Group (LON:BAB) was upgraded by analysts at Citigroup Inc. to a buy rating. The firm currently has GBX 1,554 price target on the stock.

The Berkeley Group (LON:BKG) was upgraded by analysts at Royal Bank Of Canada to a sector perform rating. The firm currently has GBX 3,900 target price on the stock.

Barratt Redrow (LON:BTRW) was upgraded by analysts at Royal Bank Of Canada to an outperform rating. The firm currently has GBX 350 target price on the stock, down from their previous target price of GBX 425.

First Citizens BancShares (NASDAQ:FCNCA) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $2,200.00 target price on the stock, down from their previous target price of $2,450.00.

Hope Bancorp (NASDAQ:HOPE) was upgraded by analysts at Brean Capital from a neutral rating to a buy rating.

Ivanhoe Mines (TSE:IVN) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. They currently have C$14.50 target price on the stock, down from their previous target price of C$19.00.

Ivanhoe Mines (TSE:IVN) was downgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a market perform rating. The firm currently has C$17.00 price target on the stock, down from their previous price target of C$23.00.

JPMorgan Chase & Co. (NYSE:JPM) had its buy rating reaffirmed by analysts at Barclays PLC.

NIKE (NYSE:NKE) had its buy rating reiterated by analysts at Sanford C. Bernstein.

NIKE (NYSE:NKE) had its buy rating reiterated by analysts at Royal Bank Of Canada.

Benchmark Co. initiated coverage on shares of ServiceNow (NYSE:NOW). They issued a buy rating and a $125.00 target price on the stock.

Xylem (NYSE:XYL) had its outperform rating reissued by analysts at Oppenheimer Holdings, Inc.. They currently have a $160.00 price target on the stock, down from their previous price target of $165.00.